LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, it offers valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular and cardiac patches, which are used for closure of vessels after surgical intervention; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.
LeMaitre Vascular Dividend Announcement
• LeMaitre Vascular announced a quarterly dividend of $0.16 per ordinary share which will be made payable on 2024-12-05. Ex dividend date: 2024-11-21
• LeMaitre Vascular annual dividend for 2024 was $0.64
• LeMaitre Vascular annual dividend for 2023 was $0.56
• LeMaitre Vascular's trailing twelve-month (TTM) dividend yield is 0.66%
• LeMaitre Vascular's payout ratio for the trailing twelve months (TTM) is 33.63%
• LeMaitre Vascular's dividend growth over the last five years (2018-2023) was 14.87% year
• LeMaitre Vascular's dividend growth over the last ten years (2013-2023) was 16.65% year
LeMaitre Vascular Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-11-21 | $0.16 | quarterly | 2024-12-05 |
2024-08-15 | $0.16 | quarterly | 2024-08-29 |
2024-05-15 | $0.16 | quarterly | 2024-05-30 |
2024-03-13 | $0.16 | quarterly | 2024-03-28 |
2023-11-15 | $0.14 | quarterly | 2023-11-30 |
2023-08-16 | $0.14 | quarterly | 2023-08-31 |
2023-05-16 | $0.14 | quarterly | 2023-06-01 |
2023-03-08 | $0.14 | quarterly | 2023-03-23 |
2022-11-16 | $0.12 | quarterly | 2022-12-01 |
2022-08-24 | $0.12 | quarterly | 2022-09-08 |
2022-05-16 | $0.12 | quarterly | 2022-06-02 |
2022-03-07 | $0.12 | quarterly | 2022-03-24 |
2021-11-18 | $0.11 | quarterly | 2021-12-02 |
2021-08-25 | $0.11 | quarterly | 2021-09-09 |
2021-05-18 | $0.11 | quarterly | 2021-06-03 |
2021-03-08 | $0.11 | quarterly | 2021-03-25 |
2020-11-18 | $0.10 | quarterly | 2020-12-03 |
2020-08-26 | $0.10 | quarterly | 2020-09-10 |
2020-05-19 | $0.10 | quarterly | 2020-06-04 |
2020-03-02 | $0.10 | quarterly | 2020-03-19 |
2019-11-19 | $0.09 | quarterly | 2019-12-05 |
2019-08-20 | $0.09 | quarterly | 2019-09-05 |
2019-05-21 | $0.09 | quarterly | 2019-06-06 |
2019-03-21 | $0.09 | quarterly | 2019-04-05 |
2018-11-19 | $0.07 | quarterly | 2018-12-06 |
2018-08-21 | $0.07 | quarterly | 2018-09-06 |
2018-05-21 | $0.07 | quarterly | 2018-06-07 |
2018-03-21 | $0.07 | quarterly | 2018-04-05 |
2017-11-21 | $0.06 | quarterly | 2017-12-07 |
2017-08-21 | $0.06 | quarterly | 2017-09-07 |
2017-05-22 | $0.06 | quarterly | 2017-06-08 |
2017-03-20 | $0.06 | quarterly | 2017-04-06 |
2016-11-17 | $0.04 | quarterly | 2016-12-05 |
2016-08-18 | $0.04 | quarterly | 2016-09-06 |
2016-05-23 | $0.04 | quarterly | 2016-06-08 |
2016-03-17 | $0.04 | quarterly | 2016-04-04 |
2015-11-18 | $0.04 | quarterly | 2015-12-04 |
2015-08-18 | $0.04 | quarterly | 2015-09-03 |
2015-05-20 | $0.04 | quarterly | 2015-06-05 |
2015-03-18 | $0.04 | quarterly | 2015-04-03 |
2014-11-18 | $0.04 | quarterly | 2014-12-04 |
2014-08-19 | $0.04 | quarterly | 2014-09-04 |
2014-05-20 | $0.04 | quarterly | 2014-06-05 |
2014-03-18 | $0.04 | quarterly | 2014-04-03 |
2013-11-18 | $0.03 | quarterly | 2013-12-04 |
2013-08-19 | $0.03 | quarterly | 2013-09-04 |
2013-05-20 | $0.03 | quarterly | 2013-06-05 |
2013-03-18 | $0.03 | quarterly | 2013-04-03 |
LeMaitre Vascular Dividend per year
LeMaitre Vascular Dividend growth
LeMaitre Vascular Dividend Yield
LeMaitre Vascular current trailing twelve-month (TTM) dividend yield is 0.66%. Interested in purchasing LeMaitre Vascular stock? Use our calculator to estimate your expected dividend yield:
LeMaitre Vascular Financial Ratios
LeMaitre Vascular Dividend FAQ
Other factors to consider when evaluating LeMaitre Vascular as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy LeMaitre Vascular stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: LeMaitre Vascular's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, LeMaitre Vascular publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, LeMaitre Vascular distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from LeMaitre Vascular are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: LeMaitre Vascular sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, LeMaitre Vascular distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: LeMaitre Vascular declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of LeMaitre Vascular's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review LeMaitre Vascular's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.